#WomensMonth

SA hospitality reaches 2030 gender target early

Building South Africa's next generation of scientists starts with girls - UP launches inaugural Girls in Stem programme

Women still the primary decision-makers in SA homes

MADE POSSIBLE BY:

More #WomensMonth

Subscribe & Follow

Advertise your job vacancies

Tender to supply ARVs awarded to companies

The national Department of Health has announced the names of various pharmaceutical companies that have won the three year tender to supply antiretroviral (ARVs) to millions of patients on treatment in South Africa.

29 Dec 2014

Tender to supply ARVs awarded to companies

The tender for the 2015 - 2017, worth over R10 billion was awarded to Sonke Pharmaceuticals R3 billion, Mylan Pharmaceuticals R2.8 billion, Aspen Pharmacare R2.5 billion and Cipla Medpro R2 billion.

There are over 2.7 million people on ARV treatment in South Africa with about 1.5 million receiving the Fixed Dose Combination.

The Fixed Dose Combination was announced by Health Minister Dr Aaron Motsoaledi in April 2013 at Phedisong Clinic, Ga-Rankuwa north of Pretoria.

The department aims to have about 4.6 million people on treatment by the end of 2016.

Source: SAnews.gov.za

SAnews.gov.za is a South African government news service, published by the Government Communication and Information System (GCIS). SAnews.gov.za (formerly BuaNews) was established to provide quick and easy access to articles and feature stories aimed at keeping the public informed about the implementation of government mandates.

Go to: http://www.sanews.gov.za